Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

In a study published in the Journal of the American College of Cardiology, a team of researchers from Radcliffe Department of Medicine borrowed a brain imaging technique to spot the tell-tale disarray in heart muscle fibres that could set off a potentially fatal heart rhythm in hypertrophic cardiomyopathy.

None

Hypertrophic cardiomyopathy is the leading cause of sudden cardiac death in young people (such as the unexpected near fatal cardiac arrest suffered by the-then 23 year old footballer Fabrice Muamba), but the microscopic heart muscle abnormalities behind these tragic events can only be picked up in a post-mortem.

Now, in a study published in the Journal of the American College of Cardiology, a team of RDM researchers have borrowed a brain imaging technique to spot the tell-tale disarray in heart muscle fibres that could set off a potentially fatal heart rhythm in hypertrophic cardiomyopathy.

This is the first time that these tell-tale signs can be spotted in living patients.

Read more (Radcliffe Department of Medicine website)

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.